Company Profile
Beijing Hope International Pharmaceutical Co.,Ltd. (BHIP) is a high-tech enterprise which was approved by Beijing Municipal Science & Technology Commission(BMSTC). Main operations of BHIP are R&D and entrusted manufacture of drugs which are produced by chemical synthesis.The BHIP established R&D centre in Beijing, is committed to technology innovation, is mainly engaged in studies of synthesis and formulation of generic chemical drugs, simultaneously pays more attention to technology innovation of formulation. The BHIP helped some Chinese pharmaceutical companies to accomplish New Drug Applications (NDA) in China.The BHIP has a well experienced R&D team which includes over 20 researchers, most of them are professional of some fields such as medicine, pharmaceutical and chemical synthesis etc.; In Tianjin(Tianjin, China),Ji'nan(Shangdong, China) and Guan(Hebei,China) etc., The BHIP cooperated with some local Pharm & Chem enterprises in producing many raw and intermediate materials and active ingredients used in manufacturing drugs.In Beijing(Beijing, China),Nanjing(Jiangsu, China) and Xi'an(Shanxi,China) etc., The BHIP built up and kept good relations with the local famous pharmaceutical enterprises in technology cooperation.Our aim is to share resources and benefits with our clients, our principle is honesty and fairness, we are actively exploring into the path of development.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
(S)-2-hydroxy-3-methoxy-3,3-diphenylpropanoic acid |
Benzenepropanoicacid,a-hydroxy-b-methoxy-b-phenyl-,(aS)-;(S)-2-hydroxy-3-methoxy-3,3-diphenylpropanoic acid;(S)-2-Hydroxy-3-methoxy-3,3-diphenylpropionic acid;(S)-2-Hydroxyl -3-Methoxy-3,3-diphenylpropanoic acid;AMbrisentan InterMediate;Ambrisentan Hydroxy Acid Impurity;(S)-2-Hydroxy-3-methoxy-3,3-diphenylpropionic Acid;ALST-3 |
178306-52-0 | Inquiry | |
2-Cyclopropyl-4-(4-fluorophenyl)-quinolyl-3-methanol |
3-Quinolinemethanol,2-cyclopropyl-4-(4-fluorophenyl)-;2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinemethanol;[2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]methanol;2-Cyclopropyl-4-(4′-fluorophenyl) quinolyl-3-methanol;2-Cyclopropyl-3-(hydroxymethyl)-4-(4-fluorophenyl)quinoline |
121660-11-5 | Inquiry | |
2-Fluoroadenine |
9H-Purin-6-amine,2-fluoro-;Adenine,2-fluoro-;1H-Purin-6-amine,2-fluoro-;2-Fluoro-9H-purin-6-amine;2-Fluoro-6-aminopurine;2-Fluoroadenine;NSC 27364;2-Fluoro-1H-purin-6-amine;2-Fluoro-7H-purin-6-amine;18916-91-1 |
700-49-2 | Inquiry | |
2-Hydroxy-3-methoxy-3,3-diphenylpropanoic acid methyl ester |
Benzenepropanoic acid,α-hydroxy-β-methoxy-β-phenyl-,methyl ester;Methyl 2-hydroxy-3-methoxy-3,3-diphenylpropanoate;2-Hydroxy-3-methoxy-3,3-diphenylpropionic acid methyl ester;2-Hydroxy-3-methoxy-3,3-diphenylpropanoic acid methyl ester |
178306-47-3 | Inquiry | |
2-Hydroxy-5-methylpyridine |
2(1H)-Pyridinone,5-methyl-;2(1H)-Pyridone,5-methyl-;5-Methyl-2(1H)-pyridinone;5-Methyl-2-pyridone;5-Methyl-2(1H)-pyridone;5-Methyl-2-pyridinol;2-Hydroxy-5-methylpyridine;3-Methyl-6-hydroxypyridine;5-Methyl-2-oxopyridine;5-Methyl-2-hydroxypyridine;1192-99-0 |
1003-68-5 | Inquiry | |
3-(4-Chlorobutyl)indole-5-carbonitrile |
143612-79-7 | Inquiry | ||
3-(4-Nitro-1-oxoisoindolin-2-yl)piperidin-2,6-dione |
3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione;3-(4-Nitro-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione;2,6-Piperidinedione, 3-(1,3-dihydro-4-nitro-1-oxo-2H-isoindol-2-yl)-;3-(7-nitro-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione;2,6-Piperidinedione,3-(1,3-dihydro-4-nitro-1-oxo-2H-isoindol-2-yl)-;C13H11N3O5;3-(4-Nitro-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione;202271-84-9;(3S)-3-(4-nitro-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione;Lenalidomide Impurity B |
827026-45-9 | Inquiry | |
3-Aminobenzoic acid |
3-AMINOBENZOIC ACID FOR SYNTHESIS;Between the aMino acid;3-Aminobenzoic acid Vetec(TM) reagent grade, 98%;3-Aminobenzoic (>=98.5% OR >= 99%);Mesalamine EP Impurity D;3-Abz-OH;3-Aminobenzoic acid≥ 98.5% (assay);Aminobenzenecarboxylic acid |
99-05-8 | Inquiry | |
3-Azabicyclo[3.3.0]octane hydrochloride |
Cyclopenta[c]pyrrole,octahydro-,hydrochloride (1:1);Cyclopenta[c]pyrrole,octahydro-,hydrochloride;3-Azabicyclo[3.3.0]octane hydrochloride;Octahydrocyclopenta[c]pyrrole hydrochloride |
112626-50-3 | Inquiry | |
4-Hydroxybenzaldehyde |
Benzaldehyde,4-hydroxy-;Benzaldehyde,p-hydroxy-;4-Hydroxybenzaldehyde;4-Formylphenol;p-Formylphenol;p-Oxybenzaldehyde;Parahydroxybenzaldehyde;p-Hydroxybenzaldehyde;NSC 2127;1187488-60-3 |
123-08-0 | Inquiry | |
9-Amino Minocycline Sulfate |
(4S,4aS,5aR,12aS)-9-Amino-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide sulfate;9-Aminominocycline sulfate;(4S,4aS,5aR,12aS)-9-amino-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide,sulfuric acid;9-Amino minocycline sulfate [4S-(4aα,12aα)]-9-amino-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide disulfate;9-Amino-minocycline sulfuric acid |
149934-20-3 | Inquiry | |
Agomelatine |
Acetamide,N-[2-(7-methoxy-1-naphthalenyl)ethyl]-;N-[2-(7-Methoxy-1-naphthalenyl)ethyl]acetamide;S 20098;N-[2-(7-Methoxy-1-naphthyl)ethyl]acetamide;Agomelatine;Valdoxan;N-[2-(7-Methoxynaphthalen-1-yl)ethyl]acetamide;AGO 178;Thymanax |
138112-76-2 | Inquiry | |
Ambrisentan |
Benzenepropanoic acid,α-[(4,6-dimethyl-2-pyrimidinyl)oxy]-β-methoxy-β-phenyl-,(αS)-;Benzenepropanoic acid,α-[(4,6-dimethyl-2-pyrimidinyl)oxy]-β-methoxy-β-phenyl-,(S)-;(αS)-α-[(4,6-Dimethyl-2-pyrimidinyl)oxy]-β-methoxy-β-phenylbenzenepropanoic acid;Ambrisentan;BSF 208075;LU 208075;Letairis;Volibris;(+)-(2S)-2-[(4,6-Dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic acid;(2S)-2-(4,6-Dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid |
177036-94-1 | Inquiry | |
Cyclopropyl-2-(2-fluorophenyl)ethan-1-one |
150322-73-9 | Inquiry | ||
Ethyl 5-(piperazin-1-yl)benzofuran-2-carboxylate |
163521-20-8 | Inquiry | ||
Ethyl 5-Aminobenzofuran-2-Carboxylate |
2-Benzofurancarboxylic acid,5-amino-,ethyl ester;Ethyl 5-aminobenzofuran-2-carboxylate;5-Aminobenzofuran-2-carboxylic acid ethyl ester;Ethyl 5-amino-1-benzofuran-2-carboxylate |
174775-48-5 | Inquiry | |
Ethyltrans-4-oxo-2-butenoate; |
2-Butenoic acid,4-oxo-,ethyl ester,(2E)-;Fumaraldehydic acid,ethyl ester;2-Butenoic acid,4-oxo-,ethyl ester,(E)-;Ethyl (2E)-4-oxo-2-butenoate;Ethyl trans-4-oxobutenoate;Ethyl fumaraldehydate;(E)-Ethyl 4-oxo-2-butenoate;Ethyl (E)-3-formylacrylate;Ethyl trans-4-oxo-2-butenoate;(E)-4-Oxo-2-butenoic acid ethyl ester;(2E)-4-Oxobut-2-enoic acid ethyl ester;Ethyl (2E)-4-oxobut-2-enoate;Ethyl (E)-4-oxobut-2-enoate |
2960-66-9 | Inquiry | |
Gliclazide |
Benzenesulfonamide,N-[[(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methyl-;Urea,1-(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)-;Cyclopenta[c]pyrrole,benzenesulfonamide deriv.;N-[[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methylbenzenesulfonamide;Gliclazide;Diamicron;S 1702;1-(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea;SE 1702;S 852;N-(4-Methylbenzenesulfonyl)-N′-[3-azabicyclo(3,3,0)oct-3-yl]urea;Diabezidum;Glinormax;Diabrezide;Diaprel;Glyzide;Glimicron;Diabyl;1-(3,3a,4,5,6,6a-Hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonylurea;1-(4-Methylbenzenesulfonyl)-3-[octahydrocyclopenta[c]pyrrol-2-yl]urea |
21187-98-4 | Inquiry | |
Imidazo(1,2-a)pyridine-3-aceticacid |
Imidazo[1,2-a]pyridine-3-acetic acid;2-(Imidazolo[1,2-a]pyridin-3-yl)acetic acid;2-(Imidazo[1,2-a]pyridin-3-yl)acetic acid;63907-25-5 |
17745-04-9 | Inquiry | |
lacosamide |
Propanamide,2-(acetylamino)-3-methoxy-N-(phenylmethyl)-,(2R)-;Propanamide,2-(acetylamino)-3-methoxy-N-(phenylmethyl)-,(R)-;(2R)-2-(Acetylamino)-3-methoxy-N-(phenylmethyl)propanamide;Erlosamide;SPM 927;Lacosamide;ADD 243037;Harkoseride;Vimpat;(2R)-2-Acetamido-N-benzyl-3-methoxypropanamide;(R)-2-Acetamido-N-benzyl-3-methoxypropionamide;Lacoset 50;Lacoset;Lacosamide UCB |
175481-36-4 | Inquiry |
CONTACT INFORMATION
Sign In for Details